Loading data for ELAB — first visit, this takes a few seconds.
PMGC Holdings Inc. (ELAB) Stock Price, Analysis & Data
Intrinsic value
See plans →Analyst Forecast
Stock Forecasts →You're seeing the free overview
Create a free account to explore more research on this ticker.
Latest Earnings
| Reported | Vs estimate | YoY Change | |
|---|---|---|---|
| Revenue | — | n/a | n/a |
| EPS | — | n/a | n/a |
Metrics
- Bid
- 2.51
- Market Cap
- 2.4M
- Revenue (ttm)
- 2.58M
- Net Income (ttm)
- -13.6M
- -0.27
- -1748.36
- n/a
- n/a
- P/B (ttm)
- 0.11
- P/S (ttm)
- 0.93
- Earnings Date
- n/a
- Ask
- 3.46
- Volume
- 13,583
- Avg. Volume (20D)
- 62,435
- Open
- 3.06
- Previous Close
- 3.14
- Day's Range
- 2.85 - 3.06
- 52-Week Range
- 2.58 - 2112.00
- Analyst
- n/a
- Price Target
- n/a
- Dividends
- n/a
- Ex-Dividend Date
- n/a
About PMGC Holdings Inc.
View profile →PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
PMGC Holdings Inc., doing business as NorthStrive Holdings, Inc, a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
Industry Biotechnology
Sector Healthcare
IPO Date Nov 21, 2023
Employees 32
Stock Exchange NasdaqCM
Ticker Symbol ELAB
Website https://pmgcholdings.com